Satellite Symposium:
Is Narrow-Spectrum Narrow Enough? Innovations in antibiotics and diagnostics for narrow spectrum therapy (Not Offical IDWeek Programming - This activity is supported by Debiopharm International SA - See Affiliated Events Guide)
Wednesday, October 26, 2016: 10:30 AM-1:00 PM
Room: 388-390

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the official program IDWeek 2016 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposia, Presentation Theater, or Learning Lounge.


This will be a highly interactive symposium and we ask that you bring a mobile device or your computer to the session.  We will utilize a web-based application to view slides, conduct live polling, and generate CME certificates. WiFi will be available in the session room.

Faculty:

Adolf W. Karchmer, MD

Professor of Medicine

Harvard Medical School

Former Chief, Infectious Diseases

Beth Israel Deaconess Medical Center

Boston, Massachusetts

 

Vance G. Fowler, MD

Professor of Medicine

Professor in Molecular Genetics and Microbiology

Member in the Duke Clinical Research Institute

Duke University School of Medicine

Durham, North Carolina

 

Christopher D. Doern, PhD

Assistant Professor of Pathology
Associate Director of Clinical Microbiology
Department of Pathology
Virginia Commonwealth University Health System

Richmond, Virginia

 

Richard P. Wenzel, MD, MSc

Professor and Former Chair

Department of Internal Medicine

Medical College of Virginia

Virginia Commonwealth University

Richmond, Virginia

 

Program Objectives:

Upon completion of this activity, participants will be able to:

  • Investigate the clinical potential of narrow-spectrum antibacterial agents

  • Identify properties and the clinical potential of new antibacterial agents in early and late stage development

  • Order rapid diagnostic tests for bacterial detection / identification and will be updated on newly developed technologies to optimize therapy

  • Recognize the importance of the human microbiome and impact of broad and narrow spectrum antibacterial agents upon metabolic processes

 

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Annenberg Center for Health Sciences at Eisenhower and Grant Downing Education. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

 

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Agenda subject to change and was provided by:

Grant Downing Education; 600 Grant Street, Suite 510 Denver, CO 80203 

Please contactmeetings@grantdowning.comfor more information.


Target Audience: all

Presentations:
10:30 AM
Registration and Refreshments
11:00 AM
Resistance and Treatment Options in Gram-positive Infections, Adolf W. Karchmer, MD
11:05 AM
New Drugs on the Market and in Development for Gram-positive Infection, Vance G. Fowler, MD
11:15 AM
Update on Diagnostic Tests for Identification of Bacterial Species and Their Resistance Mechanisms, Christopher D. Doern, PhD
11:35 AM
The Microbiome and the Impact of Broad vs Narrow-Spectrum Antibiotics, Richard P. Wenzel, MD, MSc
11:55 AM
Panel Discussion and Conclusions
12:15 PM
Lunch

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.